Literature DB >> 17082491

Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype.

Roza E Clempus1, Dan Sorescu, Anna E Dikalova, Lily Pounkova, Patricia Jo, George P Sorescu, Harald H H Schmidt, Bernard Lassègue, Kathy K Griendling.   

Abstract

OBJECTIVE: The mechanisms responsible for maintaining the differentiated phenotype of adult vascular smooth muscle cells (VSMCs) are incompletely understood. Reactive oxygen species (ROS) have been implicated in VSMC differentiation, but the responsible sources are unknown. In this study, we investigated the role of Nox1 and Nox4-derived ROS in this process. METHODS AND
RESULTS: Primary VSMCs were used to study the relationship between Nox homologues and differentiation markers such as smooth muscle alpha-actin (SM alpha-actin), smooth muscle myosin heavy chain (SM-MHC), heavy caldesmon, and calponin. We found that Nox4 and differentiation marker genes were downregulated from passage 1 to passage 6 to 12, whereas Nox1 was gradually upregulated. Nox4 co-localized with SM alpha-actin-based stress fibers in differentiated VSMC, and moved into focal adhesions in de-differentiated cells. siRNA against nox4 reduced NADPH-driven superoxide production in serum-deprived VSMCs and downregulated SM-alpha actin, SM-MHC, and calponin, as well as SM-alpha actin stress fibers. Nox1 depletion did not decrease these parameters.
CONCLUSIONS: Nox4-derived ROS are critical to the maintenance of the differentiated phenotype of VSMCs. These findings highlight the importance of identifying the specific source of ROS involved in particular cellular functions when designing therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082491      PMCID: PMC1868577          DOI: 10.1161/01.ATV.0000251500.94478.18

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  32 in total

1.  Vascular smooth muscle cell phenotypic modulation in culture is associated with reorganisation of contractile and cytoskeletal proteins.

Authors:  N F Worth; B E Rolfe; J Song; G R Campbell
Journal:  Cell Motil Cytoskeleton       Date:  2001-07

2.  Superoxide production and expression of nox family proteins in human atherosclerosis.

Authors:  Dan Sorescu; Daiana Weiss; Bernard Lassègue; Roza E Clempus; Katalin Szöcs; George P Sorescu; Liisa Valppu; Mark T Quinn; J David Lambeth; J David Vega; W Robert Taylor; Kathy K Griendling
Journal:  Circulation       Date:  2002-03-26       Impact factor: 29.690

3.  Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo.

Authors:  K Wingler; S Wünsch; R Kreutz; L Rothermund; M Paul; H H Schmidt
Journal:  Free Radic Biol Med       Date:  2001-12-01       Impact factor: 7.376

4.  Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury.

Authors:  Katalin Szöcs; Bernard Lassègue; Dan Sorescu; Lula L Hilenski; Liisa Valppu; Tracey L Couse; Josiah N Wilcox; Mark T Quinn; J David Lambeth; Kathy K Griendling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-01       Impact factor: 8.311

5.  Expression of Nox4 in osteoclasts.

Authors:  Su Yang; Yizhong Zhang; William Ries; Lyndon Key
Journal:  J Cell Biochem       Date:  2004-05-15       Impact factor: 4.429

6.  Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells.

Authors:  Lula L Hilenski; Roza E Clempus; Mark T Quinn; J David Lambeth; Kathy K Griendling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-12-11       Impact factor: 8.311

Review 7.  Serum response factor: toggling between disparate programs of gene expression.

Authors:  Joseph M Miano
Journal:  J Mol Cell Cardiol       Date:  2003-06       Impact factor: 5.000

Review 8.  Molecular regulation of vascular smooth muscle cell differentiation in development and disease.

Authors:  Gary K Owens; Meena S Kumar; Brian R Wamhoff
Journal:  Physiol Rev       Date:  2004-07       Impact factor: 37.312

9.  The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction.

Authors:  Kalyankar Mahadev; Hiroyuki Motoshima; Xiangdong Wu; Jean Marie Ruddy; Rebecca S Arnold; Guangjie Cheng; J David Lambeth; Barry J Goldstein
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

Review 10.  Reactive oxygen species in the vasculature: molecular and cellular mechanisms.

Authors:  Yoshihiro Taniyama; Kathy K Griendling
Journal:  Hypertension       Date:  2003-10-27       Impact factor: 10.190

View more
  152 in total

Review 1.  The Nox family of NADPH oxidases: friend or foe of the vascular system?

Authors:  Ina Takac; Katrin Schröder; Ralf P Brandes
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

Review 2.  Targeting NADPH oxidases in vascular pharmacology.

Authors:  Agata Schramm; Paweł Matusik; Grzegorz Osmenda; Tomasz J Guzik
Journal:  Vascul Pharmacol       Date:  2012-03-03       Impact factor: 5.773

3.  Activation of thromboxane receptor modulates interleukin-1β-induced monocyte adhesion--a novel role of Nox1.

Authors:  Hossein Bayat; Katrin Schröder; David R Pimentel; Ralf P Brandes; Tony J Verbeuren; Richard A Cohen; Bingbing Jiang
Journal:  Free Radic Biol Med       Date:  2012-03-09       Impact factor: 7.376

4.  cGMP-dependent protein kinase and the regulation of vascular smooth muscle cell gene expression: possible involvement of Elk-1 sumoylation.

Authors:  ChungSik Choi; Hassan Sellak; Felricia M Brown; Thomas M Lincoln
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-08-27       Impact factor: 4.733

5.  NADPH oxidase 4 mediates TGF-β-induced smooth muscle α-actin via p38MAPK and serum response factor.

Authors:  Abel Martin-Garrido; David I Brown; Alicia N Lyle; Anna Dikalova; Bonnie Seidel-Rogol; Bernard Lassègue; Alejandra San Martín; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2010-11-11       Impact factor: 7.376

Review 6.  Redox regulation of vascular remodeling.

Authors:  Keyvan Karimi Galougahi; Euan A Ashley; Ziad A Ali
Journal:  Cell Mol Life Sci       Date:  2015-10-20       Impact factor: 9.261

Review 7.  The pathobiology of diabetic vascular complications--cardiovascular and kidney disease.

Authors:  Stephen P Gray; Karin Jandeleit-Dahm
Journal:  J Mol Med (Berl)       Date:  2014-04-01       Impact factor: 4.599

Review 8.  NADPH oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury.

Authors:  Pamela W M Kleikers; K Wingler; J J R Hermans; I Diebold; S Altenhöfer; K A Radermacher; B Janssen; A Görlach; H H H W Schmidt
Journal:  J Mol Med (Berl)       Date:  2012-10-23       Impact factor: 4.599

Review 9.  ROS signaling and ER stress in cardiovascular disease.

Authors:  Cristhiaan D Ochoa; Ru Feng Wu; Lance S Terada
Journal:  Mol Aspects Med       Date:  2018-03-22

Review 10.  Role of NADPH oxidases in liver fibrosis.

Authors:  Yong-Han Paik; Jonghwa Kim; Tomonori Aoyama; Samuele De Minicis; Ramon Bataller; David A Brenner
Journal:  Antioxid Redox Signal       Date:  2014-01-24       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.